Northern Trust’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Sell |
173,276
-29,306
| -14% | -$469K | ﹤0.01% | 2804 |
|
|
2025
Q1 | $3.08M | Sell |
202,582
-2,204
| -1% | -$33.5K | ﹤0.01% | 2683 |
|
|
2024
Q4 | $4.15M | Buy |
204,786
+13,603
| +7% | +$276K | ﹤0.01% | 2615 |
|
|
2024
Q3 | $4.92M | Buy |
191,183
+143,769
| +303% | +$3.7M | ﹤0.01% | 2486 |
|
|
2024
Q2 | $610K | Buy |
47,414
+11,312
| +31% | +$145K | ﹤0.01% | 3435 |
|
|
2024
Q1 | $827K | Buy |
36,102
+13,729
| +61% | +$314K | ﹤0.01% | 3393 |
|
|
2023
Q4 | $586K | Buy |
22,373
+19,327
| +635% | +$506K | ﹤0.01% | 3494 |
|
|
2023
Q3 | $85.6K | Buy |
3,046
+545
| +22% | +$15.3K | ﹤0.01% | 4049 |
|
|
2023
Q2 | $76K | Sell |
2,501
-13,835
| -85% | -$421K | ﹤0.01% | 4109 |
|
|
2023
Q1 | $307K | Sell |
16,336
-331
| -2% | -$6.22K | ﹤0.01% | 3661 |
|
|
2022
Q4 | $170K | Sell |
16,667
-707
| -4% | -$7.21K | ﹤0.01% | 3935 |
|
|
2022
Q3 | $457K | Buy |
17,374
+1,106
| +7% | +$29.1K | ﹤0.01% | 3546 |
|
|
2022
Q2 | $734K | Sell |
16,268
-166
| -1% | -$7.49K | ﹤0.01% | 3420 |
|
|
2022
Q1 | $1.62M | Sell |
16,434
-371
| -2% | -$36.5K | ﹤0.01% | 3196 |
|
|
2021
Q4 | $2.57M | Buy |
16,805
+8,506
| +102% | +$1.3M | ﹤0.01% | 3102 |
|
|
2021
Q3 | $1.13M | Sell |
8,299
-979
| -11% | -$133K | ﹤0.01% | 3514 |
|
|
2021
Q2 | $1.36M | Buy |
+9,278
| New | +$1.36M | ﹤0.01% | 3458 |
|